The lawsuits keep piling on the onetime rising star of medtech. Partner Fund Management, which invested $96.1 million in Theranos in 2014, is accusing CEO Elizabeth Holmes and former COO Ramesh Balwani, of lying to investors about the company’s now-discredited blood-testing technology, Fortune reports. The lawsuit was filed Monday and unsealed yesterday, Fortune reports, and alleges securities fraud among other violations. Theranos has denied the claims in a statement. Read more here. CZ
collectionsInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.